Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hy droxy17-(1-propynyl)-estra-4,9-dien-3-one in the treatement of major depressive disorder

Details for Australian Patent Application No. 2002348996 (hide)

International Classifications

Event Publications

13 March 2003 Complete Application Filed

Priority application(s): 01204072.1 26.10.01 EP

10 July 2003 Application Open to Public Inspection

Published as AU-B-2002348996

2 November 2006 Assignment before Grant

Akzo Nobel N.V. The application has been assigned to N.V. Organon

5 June 2008 Application Accepted

Published as AU-B-2002348996

2 October 2008 Standard Patent Sealed

12 May 2011 Assignment Registered

N.V. Organon The patent has been assigned to Pop Test Cortisol LLC Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.